Fighting the burden of chronic kidney disease by frequent albuminuria screening in risk group patients
Chronic kidney disease (CKD) is a severe complication in context of various civilisation diseases, such as diabetes, hypertension, and obesity. With increasing treatment cost along the progression of CKD towards end-stage renal failure (ESRF) and the need for renal replacement therapies, CKD is not only a driver of premature mortality and diminished quality of life of affected individuals, but also puts significant burden on the society and healthcare expenditures. The early detection of kidney damage through a frequent screening of risk patients could help to fight the burden of CKD. Cost-efficient routine urinalysis data could play a vital role in providing valuable information for screening, diagnosing, and monitoring of renal disorders.
How innovative technology leads to a faster diagnosis and more targeted treatment of UTI
Urinary tract infections (UTI) belong to the most common bacterial infections and, though suspected cases often turn out to be negative, contribute to high laboratory workloads and empiric prescription of antibiotics, a main driver antimicrobial resistance (AMR). This white paper reviews the strengths of the UF-series in ruling-out UTI, supporting its diagnosis and potential applications to further optimise the UTI laboratory workflow, aiming to fight AMR.
Kidney disease, the silent epidemic knocking on our doors
The intended objective of this newsletter is to highlight the importance of early detection of chronic kidney disease (CKD). The diagnosis of CKD often require the input of many disciplines along side that of the primary health care giver. It is common for patients with CKD to also have other chronic conditions, including but not restricted to hypertension, diabetes and cardiovascular disease.